BeOne Medicines (ONC) Current Taxes (2016 - 2026)

BeOne Medicines (ONC) has reported Current Taxes for 11 consecutive years, with $63.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Taxes rose 86.04% year-over-year to $63.5 million; the TTM figure through Mar 2026 stood at $63.5 million (up 86.04% YoY), while the FY2025 annual figure was $41.6 million, up 60.53% from the prior year.
• Current Taxes grew to $63.5 million in Q1 2026 per ONC's latest filing, from $41.6 million in the prior quarter.
• Across five years, Current Taxes topped out at $63.5 million in Q1 2026 and bottomed at $5.3 million in Q2 2024.
• Historically, Current Taxes has averaged $25.0 million across 5 years, with a median of $23.0 million in 2023.
• Annual changes were most pronounced in 2024 — Current Taxes sank 69.09% — and 2026, when it soared 86.04%.
• BeOne Medicines' Current Taxes stood at $25.2 million in 2022, then decreased by 8.88% to $23.0 million in 2023, then gained by 12.98% to $25.9 million in 2024, then soared by 60.53% to $41.6 million in 2025, then jumped by 52.61% to $63.5 million in 2026.
• Business Quant data shows ONC's Current Taxes at $63.5 million in Q1 2026, $41.6 million in Q4 2025, and $11.2 million in Q3 2025.